We want to reward those who are pushing the boundaries of what can be done with DNA or RNA while contributing to the scientific idea pipeline for cancer, personalized medicine or infectious disease research.
Ottawa, ON (PRWEB) October 11, 2011
DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, today launched a grant program that encompasses three primary areas of focus – cancer, personalized medicine and infectious disease.
The DNA Genotek Grant Program invites research proposals that showcase innovative and novel use of the company’s saliva-based collection and stabilization products in the genetic/genomic bases of one of the designated research areas. Notable proposals for the use of DNA Genotek products in research focused on other disease(s) are also encouraged. The winning research proposal will receive up to $30,000 US and up to 500 DNA Genotek sample collection kits.
“We created the DNA Genotek Grant Program to reward scientists who are accelerating the application of genetics to gain knowledge in three critical areas of research”, said Ian Curry, president, DNA Genotek Inc. “We want to reward those who are pushing the boundaries of what can be done with DNA or RNA while contributing to the scientific idea pipeline for cancer, personalized medicine or infectious disease research.”
Investigators must submit an application online before Monday, January 16th, 2012. The winner will be notified in March of 2012. For more information about the grant program or to apply, visit http://www.dnagenotek.com/grant
DNA Genotek will have information on the grant program available at the International Congress of Human Genetics (ICHG) and the American Society of Human Genetics (ASHG) annual meetings in Montreal, QC (booth # 1004). Additional information will be available at DNA Genotek’s information session at ICHG/ASHG on Wednesday, October 12, 2011 at the Le Centre Sheraton Hotel, Salon 4/5, Level 2 at 7:00 p.m.
About DNA Genotek:
DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), focuses on providing high-quality biological sample collection, stabilization and preparation products. The company’s Oragene® family of products provides the best way to collect and preserve large amounts of DNA or RNA from saliva. The company also offers a family of products for collecting DNA from animals and livestock. The reliability and ease-of-use of the company’s products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 100 countries. For more information about DNA Genotek, visit http://www.dnagenotek.com
® Oragene is a registered trademark of DNA Genotek, Inc.
™ OMNIgene is a trademark of DNA Genotek, Inc.